A detailed history of Hikari Power LTD transactions in Amgen Inc stock. As of the latest transaction made, Hikari Power LTD holds 30,990 shares of AMGN stock, worth $9.93 Million. This represents 0.87% of its overall portfolio holdings.

Number of Shares
30,990
Previous 30,990 -0.0%
Holding current value
$9.93 Million
Previous $8.81 Million 9.9%
% of portfolio
0.87%
Previous 0.76%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 25, 2023

SELL
$218.65 - $271.46 $1.14 Million - $1.42 Million
-5,220 Reduced 14.42%
30,990 $8.33 Million
Q2 2022

Jul 06, 2022

BUY
$230.71 - $256.74 $76,134 - $84,724
330 Added 0.92%
36,210 $8.81 Million
Q1 2022

Apr 13, 2022

BUY
$219.27 - $242.57 $166,645 - $184,353
760 Added 2.16%
35,880 $8.68 Million
Q4 2021

Jan 12, 2022

BUY
$198.88 - $227.6 $338,096 - $386,920
1,700 Added 5.09%
35,120 $7.9 Million
Q3 2021

Oct 13, 2021

BUY
$212.27 - $248.7 $169,816 - $198,960
800 Added 2.45%
33,420 $7.11 Million
Q2 2020

Aug 13, 2020

SELL
$197.81 - $242.74 $203,744 - $250,022
-1,030 Reduced 3.06%
32,620 $7.69 Million
Q2 2019

Aug 08, 2019

SELL
$166.7 - $195.41 $80,016 - $93,796
-480 Reduced 1.41%
33,650 $6.2 Million
Q3 2018

Oct 31, 2018

SELL
$185.29 - $208.89 $2.59 Million - $2.92 Million
-14,000 Reduced 29.09%
34,130 $7.08 Million
Q2 2018

Aug 02, 2018

SELL
$166.05 - $186.51 $1.88 Million - $2.12 Million
-11,340 Reduced 19.07%
48,130 $8.88 Million
Q1 2018

May 14, 2018

BUY
$169.43 - $198.0 $254,145 - $297,000
1,500 Added 2.59%
59,470 $10.1 Million
Q3 2017

Nov 08, 2017

BUY
$167.29 - $191.0 $2.55 Million - $2.92 Million
15,270 Added 35.76%
57,970 $10.8 Million
Q2 2017

Aug 09, 2017

BUY
N/A
42,700
42,700 $7.35 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $171B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Hikari Power LTD Portfolio

Follow Hikari Power LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hikari Power LTD, based on Form 13F filings with the SEC.

News

Stay updated on Hikari Power LTD with notifications on news.